184 related articles for article (PubMed ID: 31448438)
1. Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.
Flores-Climente V; Rozas-Muñoz E; Martínez-Grau A; Aucouturier F; Luna S; Baselga E
Pediatr Dermatol; 2019 Nov; 36(6):984-985. PubMed ID: 31448438
[TBL] [Abstract][Full Text] [Related]
2. [Rituximab use in mucous membrane pemphigoid].
Bertrand AS; Dereure O; Girard C; Bessis D; Guillot B
Ann Dermatol Venereol; 2019 Oct; 146(10):659-661. PubMed ID: 31358309
[No Abstract] [Full Text] [Related]
3. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
[TBL] [Abstract][Full Text] [Related]
4. Disease Relapse After Drug-Free Remission in Ocular Mucous Membrane Pemphigoid.
Shifera AS; Hong GH; Khan IR; Okeagu C; Thorne JE
Am J Ophthalmol; 2021 Mar; 223():21-27. PubMed ID: 32976845
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab.
Baniel A; Oestreicher-Kedem Y; Peled A; Bar-Ilan E; Geller S; Sprecher E; Baum S
Clin Exp Dermatol; 2021 Jul; 46(5):915-919. PubMed ID: 33811681
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid.
Witte M; Zillikens D; Shimanovich I
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e321-e324. PubMed ID: 29443427
[No Abstract] [Full Text] [Related]
7. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab.
Huff SB; Vasu S; Kaffenberger BH
Int J Dermatol; 2019 Feb; 58(2):240-241. PubMed ID: 29707776
[No Abstract] [Full Text] [Related]
8. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
Front Immunol; 2022; 13():915205. PubMed ID: 35844526
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
Front Immunol; 2018; 9():248. PubMed ID: 29520266
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.
Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M
Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558
[No Abstract] [Full Text] [Related]
12. Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019.
Bamberger F; König IR; Gola D; Zillikens D; Sadik CD
Front Immunol; 2023; 14():1180150. PubMed ID: 37143653
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of mucous membrane pemphigoid with tacrolimus.
Suresh L; Martinez Calixto LE; Radfar L
Spec Care Dentist; 2006; 26(2):66-70. PubMed ID: 16681241
[TBL] [Abstract][Full Text] [Related]
14. Mucous Membrane Pemphigoid: A Case Report with Oral and Ocular Presentation.
Fageeh HI
J Contemp Dent Pract; 2022 Jul; 23(7):755-759. PubMed ID: 36440525
[TBL] [Abstract][Full Text] [Related]
15. Rituximab preserves vision in ocular mucous membrane pemphigoid.
Rübsam A; Stefaniak R; Worm M; Pleyer U
Expert Opin Biol Ther; 2015 Jul; 15(7):927-33. PubMed ID: 25966960
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
[TBL] [Abstract][Full Text] [Related]
17. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
Taverna JA; Lerner A; Bhawan J; Demierre MF
J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
[TBL] [Abstract][Full Text] [Related]
18. Mucous membrane pemphigoid: recent advances.
Srikumaran D; Akpek EK
Curr Opin Ophthalmol; 2012 Nov; 23(6):523-7. PubMed ID: 23047169
[TBL] [Abstract][Full Text] [Related]
19. Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.
Nishimura R; Fujimoto N; Kito K; Uchiyama K; Koga H; Hodohara K; Hashimoto T; Fujiyama Y; Tanaka T
Eur J Dermatol; 2013; 23(4):562-4. PubMed ID: 24001878
[No Abstract] [Full Text] [Related]
20. Anti-laminin 332 mucous membrane pemphigoid with laryngeal involvement - adjuvant treatment with immunoadsorption and rituximab.
Hügel R; Lang A; Lhotta K; Elsässer W; Gächter J; Messmer EM; Schmidt E
J Dtsch Dermatol Ges; 2018 Jul; 16(7):897-900. PubMed ID: 29927519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
